rs200674715
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001110219.3(GJB6):āc.607A>Gā(p.Met203Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000449 in 1,614,076 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001110219.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJB6 | NM_001110219.3 | c.607A>G | p.Met203Val | missense_variant | 5/5 | ENST00000647029.1 | NP_001103689.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GJB6 | ENST00000647029.1 | c.607A>G | p.Met203Val | missense_variant | 5/5 | NM_001110219.3 | ENSP00000493834.1 |
Frequencies
GnomAD3 genomes AF: 0.000802 AC: 122AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000736 AC: 185AN: 251404Hom.: 1 AF XY: 0.000721 AC XY: 98AN XY: 135880
GnomAD4 exome AF: 0.000412 AC: 602AN: 1461878Hom.: 3 Cov.: 32 AF XY: 0.000433 AC XY: 315AN XY: 727240
GnomAD4 genome AF: 0.000802 AC: 122AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.00109 AC XY: 81AN XY: 74360
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 22, 2011 | Met203Val in exon 3 of GJB6: This variant is not expected to have clinical signi ficance. It has been identified in 1% (2/214) of a population studied for suscep tibility to noise, but did not include childhood hearing loss patients (Carlsson 2007). In addition, this variant is not conserved across all species and comput ational analyses (biochemical amino acid properties, PolyPhen2, SIFT, AlignGVGD) do not predict an impact to the protein. - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 07, 2022 | Variant summary: GJB6 c.607A>G (p.Met203Val) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00074 in 251404 control chromosomes in the gnomAD database, including 1 homozygote. The observed variant frequency is approximately 4700 fold of the estimated maximal expected allele frequency for a pathogenic variant in GJB6 causing Hidrotic Ectodermal Dysplasia Syndrome phenotype (1.6e-07), strongly suggesting that the variant is benign. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign. Based on the evidence outlined above, the variant was classified as benign. - |
Hidrotic ectodermal dysplasia syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Hidrotic ectodermal dysplasia syndrome;C2673759:Autosomal recessive nonsyndromic hearing loss 1A;C2675235:Autosomal recessive nonsyndromic hearing loss 1B;C2675237:Autosomal dominant nonsyndromic hearing loss 3B Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
GJB6-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 11, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at